Brain metastases
Achal S. Achrol(Institute for Stem Cell Biology and Regenerative Medicine), Lakshmi Nayak(Dana-Farber Cancer Institute), Nils D. Arvold(Dana-Farber Cancer Institute), Patricia S. Steeg(National Cancer Institute), Manmeet S. Ahluwalia(Baptist Hospital of Miami), Solange Peters(University Hospital of Lausanne), Riccardo Soffietti(Azienda Ospedaliero Universitaria San Giovanni Battista), Robert C. Rennert(University of California San Diego), Carey K. Anders(Duke University), Griffith R. Harsh(Stanford Medicine)
Cited by 1,053
Related Papers
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
|Annals of Oncology|2018|2.9k
Alectinib versus Crizotinib in Untreated <i>ALK</i>-Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2017|2.4k
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|2.3k
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k